Italian Sarcoma Group

🇮🇹Italy

Country: 🇮🇹Italy

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.italiansarcomagroup.org/

Clinical Trials

Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStars

Recruiting

Conditions: Angiosarcoma

Interventions: Other: Observational

First Posted Date: 2024-04-19

Last Posted Date: 2024-12-17

Lead Sponsor: Italian Sarcoma Group

Target Recruit Count: 250

Registration Number: NCT06375941

Locations: 🇮🇹
Fondazione Policlinico Campus Biomedico, Roma, Italy
🇮🇹
IRCCS Istituto Nazionale Tumori - Milano, Milano, Italy
🇮🇹
IOV Istituto Oncologico Veneto IRCCS, Padova, Italy

and more 1 locations

Observational Study in Localized Osteosarcoma

Recruiting

Conditions: Localized Osteosarcoma

Interventions: Other: Treatment of Osteosarcoma according the AIEOP/ISG OS 2021 recommendations (includes drugs, surgery, radiotherapy or any other received treatments)

First Posted Date: 2021-05-18

Last Posted Date: 2024-12-20

Lead Sponsor: Italian Sarcoma Group

Target Recruit Count: 120

Registration Number: NCT04890067

Locations: 🇮🇹
A.O. Universitaria Meyer, Firenze, Italy
🇮🇹
Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy
🇮🇹
Sandra Aliberti, Candiolo, Torino, Italy

and more 13 locations

Observational Study on Skeletal Ewing's Sarcoma

Recruiting

Conditions: Ewing Sarcoma of Bone

Interventions: Other: Treatment of Ewings Sarcoma of bone according clinical practice (includes drugs, surgery, radiotherapy or any other received treatments)

First Posted Date: 2021-04-15

Last Posted Date: 2024-12-20

Lead Sponsor: Italian Sarcoma Group

Target Recruit Count: 100

Registration Number: NCT04845893

Locations: 🇮🇹
FONDAZIONE IRCCS Istituto Nazionale dei Tumori, Milano, Italy
🇮🇹
Istituto Clinico Humanitas, Rozzano, MI, Italy
🇮🇹
Azienda ospedaliero universitaria consorziale policlinico - bari, Bari, Italy

and more 15 locations

Study on Clinical Features and Outcomes of Breast Sarcoma

Recruiting

Conditions: Breast Sarcoma

Interventions: Other: Treatment of Breast Sarcoma according clinical practice (includes drugs, surgery or any other received treatments)

First Posted Date: 2021-02-11

Last Posted Date: 2024-12-20

Lead Sponsor: Italian Sarcoma Group

Target Recruit Count: 300

Registration Number: NCT04749446

Locations: 🇮🇹
Azienda Ospedaliera S. Orsola-Malpighi, Bologna, BO, Italy
🇮🇹
Azienda Ospedaliera Universitaria Paolo Giaccone, Palermo, PA, Italy
🇮🇹
A.O Ospedali Riuniti Marche Nord, Ancona, Italy

and more 11 locations

Study in Low Risk Gastrointestinal Stromal Tumor (GISTs)

Completed

Conditions: GIST

Interventions: Other: Treatment of Low Risk GISTs according clinical practice (includes drugs, surgery or any other received treatments)

First Posted Date: 2020-10-23

Last Posted Date: 2024-02-01

Lead Sponsor: Italian Sarcoma Group

Target Recruit Count: 700

Registration Number: NCT04599660

Locations: 🇮🇹
Fondazione IRCCS INT Milano, Milano, Italy
🇮🇹
Azienda Ospedaliero-Universitaria Di Bologna, Bologna, BO, Italy
🇮🇹
Istituto Clinico Humanitas, Rozzano, MI, Italy

and more 10 locations

Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma

Phase 2

Recruiting

Conditions: Leiomyosarcoma of Ovary
Soft Tissue Sarcoma

Interventions: Drug: Gemcitabine
Drug: Trabectedin

First Posted Date: 2020-05-12

Last Posted Date: 2024-12-20

Lead Sponsor: Italian Sarcoma Group

Target Recruit Count: 100

Registration Number: NCT04383119

Locations: 🇮🇹
Nuovo Ospedale di Prato, Prato, Firenze, Italy
🇮🇹
IRCCS Fondazione Piemonte per l'Oncologia, Candiolo, Torino, Italy
🇮🇹
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST, Meldola, FC, Italy

and more 14 locations

Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma

Phase 2

Recruiting

Conditions: Mesenchymal Chondrosarcoma

Interventions: Drug: Trabectedin

First Posted Date: 2020-03-12

Last Posted Date: 2024-12-20

Lead Sponsor: Italian Sarcoma Group

Target Recruit Count: 16

Registration Number: NCT04305548

Locations: 🇮🇹
Nuovo Ospedale di Prato, Prato, Firenze, Italy
🇮🇹
Policlinico Universitario Campus Biomedico, Roma, RM, Italy
🇮🇹
Fondazione del Piemonte per l'Oncologia IRCC Candiolo, Candiolo, Torino, Italy

and more 4 locations

Study on TSR-042 in Advanced Clear Cell Sarcoma

Phase 2

Terminated

Conditions: Sarcoma, Clear Cell

Interventions: Drug: TSR-042

First Posted Date: 2020-02-18

Last Posted Date: 2024-02-01

Lead Sponsor: Italian Sarcoma Group

Target Recruit Count: 3

Registration Number: NCT04274023

Locations: 🇮🇹
Fondazione IRCSS Istituto Nazionale dei Tumori, Milan, Italy

Eribulin in Advanced Solitary Fibrous Tumor

Phase 2

Recruiting

Conditions: Solitary Fibrous Tumor

Interventions: Drug: Eribulin

First Posted Date: 2019-02-15

Last Posted Date: 2023-09-13

Lead Sponsor: Italian Sarcoma Group

Target Recruit Count: 16

Registration Number: NCT03840772

Locations: 🇮🇹
Azienda Ospedaliera Universitaria Paolo Giaccone, Palermo, PA, Italy
🇮🇹
Policlinico Universitario Campus Biomedico, Roma, RM, Italy
🇮🇹
Fondazione IRCCS INT Milano, Milano, Italy

Randomized Trial in Advanced, Metastatic or Unresectable Soft Tissue Sarcoma After Failure of Standard Treatments.

Phase 2

Completed

Conditions: Advanced Soft Tissue Sarcoma

First Posted Date: 2019-02-12

Last Posted Date: 2024-12-04

Lead Sponsor: Italian Sarcoma Group

Target Recruit Count: 130

Registration Number: NCT03838744

Locations: 🇮🇹
Azienda Ospedaliera Universitaria Paolo Giaccone, Palermo, PA, Italy
🇮🇹
Istituto Ortopedico Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors, Bologna, Italy
🇮🇹
Azienda Ospedaliero-Universitaria Di Bologna, Bologna, BO, Italy

and more 10 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy